Drug Type Antibody |
Synonyms |
Target |
Mechanism HBV pre-S1 inhibitors(HBV pre-S1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Phase 1 | CN | 30 Jan 2022 | |
Hepatitis D | Phase 1 | CN | 30 Jan 2022 | |
Hepatitis B, Chronic | IND Approval | CN | 07 Oct 2023 |